Maryland Trim Clinic describes regular follow-up and side-effect monitoring as part of its GLP-1 service
Second, on January 1, 2026 the OSU Health Plan discontinued GLP-1 weight-management coverage with no exceptions, citing unsustainable cost only Type 2 diabetes use is now covered
This route of administration is consistent with other approved GLP-1 receptor agonist therapies and is generally well tolerated when performed correctly
Reactive lymphadenopathy from recent vaccinations is increasingly recognized, particularly following COVID-19 vaccination, which can cause axillary lymph node enlargement on the ipsilateral side
Of note, TH gene expression was substantially upregulated in the AP following GLP-1RA administration (Figure 8A), as demonstrated previously using complementary methods (64)
65StromSC, FisherRA, ThompsonMT,